Stock TradingThermo Fisher Closes $8.9B Clario Deal to Accelerate AI Drug Trials
Thermo Fisher Scientific completes its $8.875B acquisition of Clario, adding AI-powered clinical trial data tools that have supported 70% of FDA novel drug approvals in a decade.
Jake Trader★Mar 26, 2026★4 min read
